Company data
Relay Therapeutics, Inc. employees and revenue per employee
RLAY · Biotechnology · $3.56B market cap
Relay Therapeutics, Inc. had 192 employees at the end of fiscal Dec 2025, down 26.4% from a year earlier. Revenue for the year was $15.4M, up 53.4% from a year earlier, or $80K per employee. Revenue held up or grew while headcount stayed flat or fell.
Employees
192
-26.4% YoY
Revenue
$15.4M
+53.4% YoY
Revenue / employee
$80K
Peer median $457K
Rank in industry
94 of 110
Biotechnology
Open roles
15
78 per 1,000 staff
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 192 | $15.4M | $80K | -26.4% | +53.4% |
| Dec 2024 | 261 | $10.0M | $38K | -19.2% | -60.8% |
| Dec 2023 | 323 | $25.5M | $79K | -1.2% | +1749.8% |
| Dec 2022 | 327 | $1.4M | $4K | +33.5% | -54.4% |
| Dec 2021 | 245 | $3.0M | $12K | +54.1% | -96.3% |
| Dec 2020 | 159 | $82.7M | $520K | — | — |
Open roles on its job board: 15 (78 per 1,000 staff, against its latest annual headcount), as of 2026-11-20. Tracked since 2026-10-03. No 90 day change yet.
Relay Therapeutics, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| CBIO Crescent Biopharma, Inc. | 44 | $10.8M | $246K | — |
| OABI OmniAb, Inc. | 89 | $18.7M | $210K | Contracting |
| CAPR Capricor Therapeutics, Inc. | 160 | $22.3M | $139K | Hiring into decline |
| ALMS Alumis Inc. | 221 | $24.1M | $109K | — |
| JANX Janux Therapeutics, Inc. | 109 | $10.0M | $92K | Hiring into decline |
| RLAY Relay Therapeutics, Inc. | 192 | $15.4M | $80K | Leaner |
| PRAX Praxis Precision Medicines, Inc. | 116 | $8.6M | $74K | Efficient growth |
| PGEN Precigen, Inc. | 160 | $9.7M | $61K | Efficient growth |
| ZBIO Zenas BioPharma, Inc. | 167 | $10.0M | $60K | Efficient growth |
Questions about Relay Therapeutics, Inc.
- How many employees does Relay Therapeutics, Inc. have?
- Relay Therapeutics, Inc. reported 192 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is down 26.4% from a year earlier.
- What is Relay Therapeutics, Inc.'s revenue per employee?
- Relay Therapeutics, Inc. brought in $15.4M of revenue in fiscal Dec 2025, which is $80K per employee. That ranks 94 of 110 companies we track in Biotechnology, where the median is $457K.
- Is Relay Therapeutics, Inc. hiring?
- Relay Therapeutics, Inc.'s public job board listed 15 open roles on November 20, 2026, about 78 per 1,000 staff.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Outpick research
This page is the filings. The research is a membership.
On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare RLAY with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Relay Therapeutics, Inc.'s annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell RLAY.